A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors
Clinical trial NCT00994071 · COMPLETED
Trial details
- NCT number
- NCT00994071
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.